Nitisinone News
Nitisinone currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Nitisinone with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of adult and paediatric patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
- Evidence level: L5
- Predicted indications (20):
- renal tubular acidosis (100.0%)
- galactosemia (100.0%)
- serpinopathy with toxic serpin polymerization (99.9%)
- C1 inhibitor deficiency (99.9%)
- glycogen storage disease (99.9%)
- adult polyglucosan body disease (99.9%)
- glycogen storage disease due to glucose-6-phosphatase deficiency (99.9%)
- Griscelli syndrome (99.9%)
- granulomatous disease, chronic, X-linked (99.9%)
- ermine phenotype (99.9%)
- ocular albinism (disease) (99.9%)
- piebaldism (99.9%)
- ocular albinism with sensorineural deafness (99.9%)
- anemia, nonspherocytic hemolytic, due to G6PD deficiency (99.8%)
- cold agglutinin disease (99.8%)
- primary CD59 deficiency (99.8%)
- hemolytic anemia due to diphosphoglycerate mutase deficiency (99.8%)
- cholelithiasis (99.8%)
- albinism (99.8%)
- classic galactosemia (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.